FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,872 letters match. Newest first.

  1. Tower Laboratories Ltd.

    FDA warned Tower Laboratories, an OTC drug maker in Montague, MI, for weak out-of-specification investigations and unproven test methods.

    High risk
  2. LiquidCapsule Manufacturing, LLC

    LiquidCapsule Manufacturing failed CGMP (current good manufacturing practice) for OTC drugs, including component identity testing and process validation failures.

    High risk
  3. Agebox Inc.

    Agebox Inc. sells iKids-Growth children's supplements containing the undeclared, unapproved drug ibutamoren, making them unapproved and misbranded drugs.

    High risk
  4. Unipack LLC

    FDA says Unipack LLC released suppositories without adequate out-of-specification investigations, complete lab records, and required USP testing.

    High risk
  5. Private Label Skin Care, Inc.

    FDA warned Private Label Skin Care about poor quality oversight, continued sale of impurity-affected over-the-counter drugs, and missing drug listings.

    High risk
  6. Palamur Biosciences Private Limited

    FDA warns Palamur Biosciences over GLP violations in medical device safety testing and inadequate corrective actions.

    High risk
  7. Devalingam Mahalingam, M.D., Ph.D.

    FDA warns clinical investigator Devalingam Mahalingam, M.D., Ph.D. over a 100-fold investigational drug overdose that led to a subject's death.

    High risk
  8. Guangdong Renhe Guozhuang Biotechnology Co., Ltd.

    FDA warns Guangdong Renhe Guozhuang Biotechnology over CGMP failures in OTC drug manufacturing.

    High risk
  9. Atomix LLC

    FDA warned Atomix LLC that its website sells unapproved SARM drugs MK-2866 and RAD-140 as new drugs without approval.

    High risk
  10. Prime Sports Nutrition

    FDA warns Prime Sports Nutrition that its website sells SARMs such as LGD-4033 and RAD-140 as unapproved new drugs.

    High risk
  11. Pinnacle Professional Research dba Pinnacle Peptides

    FDA told Pinnacle Peptides its SARMs sold online are unapproved new drugs with serious safety risks.

    High risk
  12. Dynamic Health Group dba SARMS AMERICA

    FDA told SARMS AMERICA its SARMs products (Ostarine, MK-677, Cardarine, LGD-4033) are unapproved new drugs sold online without FDA approval.

    High risk
  13. Maria A. Carballosa, M.D.

    FDA warns Dr. Maria Carballosa over failure to retain clinical trial records for an investigational drug.

    Medium
  14. Medinatura New Mexico, Inc.

    FDA cited Medinatura New Mexico for drug manufacturing rule violations, including weak component testing and cleaning.

    High risk
  15. SV Labs Corporation

    SV Labs released microbe-contaminated OTC drug products and lacked water, process and quality controls, FDA says.

    High risk
  16. Darmerica, LLC

    FDA warns Darmerica over manufacturing-quality violations and mislabeled drug ingredients, including retatrutide.

    High risk
  17. King Farm

    King Farm's horse feed held fumonisin up to 36.1 ppm; FDA ties it to at least 30 horse deaths.

    High risk
  18. Revive Rx LLC dba Revive Rx Pharmacy

    FDA warns Revive Rx Pharmacy over insanitary production of sterile compounded drugs, citing contamination risks.

    High risk
  19. TG Supply LLC d/b/a TransGuy Supply

    FDA warned TransGuy Supply that its breast binders are unregistered, unlisted medical devices.

    Low
  20. Flux Lab Pte. Ltd. d/b/a The Fluxion

    FDA warns Flux Lab/The Fluxion over unregistered, unlisted chest binders marketed as medical devices.

    Medium
  21. Marli Washington Design, LLC

    Marli Washington Design (gc2b) sold breast binders as medical devices without FDA registration or listing for FY2026, making them misbranded.

    Low
  22. Early to Bed, Inc.

    FDA warned Early to Bed, Inc. that its breast binders are misbranded because the manufacturer was not registered or listed with FDA.

    Low
  23. GenderBender LLC

    GenderBender LLC sells breast binders as medical devices without FDA registration or listing, making them misbranded.

    Low
  24. TomboyX, PBC

    FDA says TomboyX sells breast binders as medical devices without registering or listing them, making them misbranded.

    Medium
  25. Philadelphia 7, Inc d/b/a Passional Boutique

    FDA says Philadelphia 7 sold unregistered, unlisted breast binders, making them misbranded devices.

    Low
  26. TOMSCOUT

    FDA says TOMSCOUT sells breast binders as medical devices without required FDA registration or listing.

    Low
  27. ShapeShifter Apparel, LLC

    FDA says ShapeShifter Apparel sold breast binders as unregistered, unlisted medical devices, making them misbranded.

    Low
  28. Trans-Missie B.V.

    FDA says Trans-Missie B.V. sells breast binders as medical devices without registering or listing them with FDA.

    Low
  29. Sklar Personal Care Inc.

    Sklar Personal Care’s drug facility failed CGMP (current good manufacturing practice), including untested raw materials and inadequate cleaning, process validation, and quality oversight.

    High risk
  30. 3D Imaging Drug Design and Development LLC

    FDA warns 3D Imaging of CGMP failures in sterile PET drug manufacturing and outdated drug listings.

    High risk
  31. Green Valley Fertility Partners

    FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.

    High risk
  32. Microvascular Tissue, Inc.

    FDA says Microvascular Tissue's mVASC wound product is an unapproved drug and unlicensed biologic, made without validated processes.

    High risk
  33. Harbor Marine Product Inc.

    FDA found Listeria bacteria on raw ready-to-eat fish contact surfaces and serious seafood HACCP and importer verification failures at Harbor Marine Product.

    High risk
  34. Bedner Growers, Inc.

    FDA: Bedner Growers' cucumbers tied to Salmonella outbreaks; packing line and product tested positive.

    High risk
  35. Longford Water Company LLC

    FDA warns Longford Water Company that its bottled drinking water was made under insanitary conditions and without required treatment validation and testing.

    High risk
  36. Target Corporation

    FDA warns Target that recalled ByHeart infant formula tied to an infant botulism outbreak stayed on store shelves in 20 states.

    High risk
  37. Walmart, Inc.

    Walmart kept recalled ByHeart infant formula on shelves in 21 states after a botulism outbreak recall, FDA says.

    High risk
  38. The Kroger Company

    FDA warned Kroger that recalled ByHeart infant formula tied to an infant botulism outbreak stayed on its store shelves.

    High risk
  39. The Albertsons Companies Incorporated

    FDA warns Albertsons that recalled ByHeart infant formula tied to 51 infant botulism cases stayed on its store shelves for days.

    High risk
  40. Catalent Indiana, LLC

    Catalent Indiana's Bloomington plant released sterile vials contaminated with mammalian hair and failed to investigate, FDA says.

    High risk
  41. Seaway Pharma Inc.

    FDA cited Seaway Pharma for manufacturing-quality rule violations in OTC oral liquid drugs, including release and component-testing failures.

    High risk
  42. CDL Services, Inc. DBA Technichem

    FDA warned CDL Services (Technichem), an Anaheim OTC drug maker, that it released hand sanitizer and hand soap batches without testing.

    High risk
  43. DeVere Manufacturing Inc.

    FDA warned DeVere Manufacturing in Janesville, Wisconsin, that its OTC hand sanitizers are adulterated after a June 2025 inspection found CGMP failures.

    High risk
  44. Envoy Medical Inc.

    Envoy Medical in Saint Paul, MN was cited for quality system failures in making its Esteem II Implantable Hearing System, including slow complaint investigations and missed cleanroom contamination risks.

    High risk
  45. Delucas Bakery Corp

    FDA warns Delucas Bakery Corp over unsanitary conditions, missing food safety plan, and undeclared allergens in ready-to-eat rolls and buns.

    High risk
  46. Rhyz Analytical Labs

    FDA warned Rhyz Analytical Labs, a contract drug testing lab, that inadequate microbial failure investigations and quality oversight made tested drugs adulterated.

    High risk
  47. PQ Pharmacy, LLC

    FDA warns PQ Pharmacy, a Florida sterile drug compounder, that its products were made under unsafe conditions.

    High risk
  48. Turbare Manufacturing

    FDA warns outsourcing facility Turbare Manufacturing of Conway, Arkansas, for making sterile drugs under insanitary conditions.

    High risk
  49. Distacart Inc.

    FDA says Distacart's website sells unapproved drugs, some claimed for malaria, asthma, depression and eye conditions.

    High risk
  50. Swift Digital Group LLC dba Swadesii

    FDA warned Swadesii that its website sells unapproved drugs with claims to treat serious conditions including measles, cancer and Alzheimer's.

    High risk